These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33809332)

  • 21. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D; Bern C; Ghosh D; Rashid M; Molina R; Chowdhury R; Nath R; Ghosh P; Chapman LAC; Alim A; Bilbe G; Alvar J
    Clin Infect Dis; 2019 Jul; 69(2):251-258. PubMed ID: 30357373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India.
    Jaiswal P; Datta S; Sardar B; Chaudhuri SJ; Maji D; Ghosh M; Saha B; Mukhopadhyay S
    PLoS One; 2018; 13(2):e0192302. PubMed ID: 29420575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Preliminary Study to Compare Recombinase Polymerase Amplification-Lateral Flow and Quantitative PCR in the Detection of Cutaneous Leishmania in Communities from the Volta Region of Ghana.
    Yeboah C; Mosore MT; Attram N; Shelite TR; Akuffo RA; Addo SO; Behene E; Agbodzi B; Bentil RE; Fox AT; Wilson M; Boakye D; Letizia AG; Melby PC; Travi BL
    Vector Borne Zoonotic Dis; 2023 Feb; 23(2):75-80. PubMed ID: 36763962
    [No Abstract]   [Full Text] [Related]  

  • 26. Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.
    Sultana A; Zakaria SM; Bhuiyan SI; Habib A; Dey SK; Rahman M; Basher A
    Mymensingh Med J; 2012 Jul; 21(3):529-32. PubMed ID: 22828555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
    Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
    Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
    BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The performance of the recombinase polymerase amplification test for detecting Leishmania deoxyribonucleic acid from skin lesions of patients with clinical or epidemiological suspicion of cutaneous leishmaniasis.
    Mesa LE; Manrique R; Robledo SM; Tabares J; Pineda T; Muskus C
    Trans R Soc Trop Med Hyg; 2021 Dec; 115(12):1427-1433. PubMed ID: 34037801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of a Recombinant Polymerase Amplification Test-Lateral Flow (RPA-LF) for cutaneous leishmaniasis in an endemic setting of Colombia.
    Cossio A; Jojoa J; Castro MDM; Castillo RM; Osorio L; Shelite TR; Gore Saravia N; Melby PC; Travi BL
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009291. PubMed ID: 33909619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Efficacy of Recombinase-Polymerase-Amplification Coupled with Lateral Flow Strip Reading in Patients with Cutaneous Leishmaniasis from the Amazonas Rainforest of Perú.
    Travi BL; Delos Santos MB; Shelite TR; Santos RP; Rosales LA; Castellanos-Gonzalez A; Saldarriaga O; Melby PC
    Vector Borne Zoonotic Dis; 2021 Dec; 21(12):941-947. PubMed ID: 34665665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of kDNA Minicircle PCR-RFLP to Characterize
    Pokhrel O; Rai K; Bhattarai NR; Rijal S; Rijal A; Khanal B
    Can J Infect Dis Med Microbiol; 2019; 2019():9392414. PubMed ID: 31467623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serodiagnosis of leishmaniasis.
    Kar K
    Crit Rev Microbiol; 1995; 21(2):123-52. PubMed ID: 7639932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The usefulness of trained field workers in diagnosis of post-kala-azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar.
    Das VNR; Siddiqui NA; Pandey K; Lal CS; Sinha SK; Bimal S; Topno RK; Singh SK; Kumar S; Das P
    Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):332-340. PubMed ID: 30920625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advancement in Molecular Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Singh R; Salotra P
    Indian J Dermatol; 2020; 65(6):465-472. PubMed ID: 33487701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.